$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000162828021020328 Filed on October 21, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$1.820M	$2.064M	$2.036M
YoY Change	0.56%	1.38%	-2.48%
Cost Of Revenue	$577.5K	$619.8K	$537.6K
YoY Change	20.31%	15.29%	-41.2%
Gross Profit	$1.243M	$1.445M	$1.499M
YoY Change	-6.57%	-3.61%	27.69%
Gross Profit Margin	68.27%	69.97%	73.6%
Selling, General & Admin	$1.250M	$1.408M	$1.104M
YoY Change	11.62%	27.55%	-47.7%
% of Gross Profit	100.6%	97.47%	73.66%
Research & Development	$997.1K	$724.6K	$652.7K
YoY Change	84.64%	11.01%	37.36%
% of Gross Profit	80.24%	50.16%	43.55%
Depreciation & Amortization	-$27.21K	$24.08K	$20.00K
YoY Change	-236.05%	20.4%	-300.0%
% of Gross Profit	-2.19%	1.67%	1.33%
Operating Expenses	$2.247M	$2.132M	$1.757M
YoY Change	35.37%	21.41%	-32.07%
Operating Profit	-$1.004M	-$688.0K	-$257.9K
YoY Change	204.39%	166.77%	-81.74%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.480K	$880.00	$774.00
YoY Change		13.7%	-89.63%
Pretax Income	-$1.003M	-$687.1K	-$260.0K
YoY Change	203.94%	164.27%	-81.43%
Income Tax
% Of Pretax Income
Net Earnings	-$1.003M	-$687.1K	-$257.1K
YoY Change	203.94%	167.23%	-81.69%
Net Earnings / Revenue	-55.11%	-33.28%	-12.63%
Basic Earnings Per Share		-$0.12	-$0.07
Diluted Earnings Per Share	-$150.8K	-$0.12	-$0.07
COMMON SHARES
Basic Shares Outstanding	6.645M shares	5.818M shares	3.785M shares
Diluted Shares Outstanding		5.818M shares	3.785M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.57M	$23.21M	$4.930M
YoY Change	331.59%	370.86%	54.55%
Cash & Equivalents	$22.57M	$23.21M	$4.929M
Short-Term Investments
Other Short-Term Assets	$598.4K	$710.1K	$680.0K
YoY Change	24.66%	4.43%	1.49%
Inventory	$706.6K	$997.0K	$1.050M
Prepaid Expenses
Receivables	$310.8K	$639.8K	$633.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$24.19M	$25.56M	$7.290M
YoY Change	241.16%	250.62%	9.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$198.7K	$204.9K	$205.7K
YoY Change	8.29%	-0.36%	-31.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$26.40K	$29.29K	$30.00K
YoY Change	-7.44%	-2.37%	0.0%
Total Long-Term Assets	$700.3K	$733.3K	$1.050M
YoY Change	-22.59%	-30.16%	-43.88%
TOTAL ASSETS
Total Short-Term Assets	$24.19M	$25.56M	$7.290M
Total Long-Term Assets	$700.3K	$733.3K	$1.050M
Total Assets	$24.89M	$26.29M	$8.340M
YoY Change	211.31%	215.27%	-1.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$284.0K	$317.0K	$192.4K
YoY Change	99.58%	64.78%	-69.88%
Accrued Expenses	$814.2K	$1.028M	$1.011M
YoY Change	-18.46%	1.7%	-61.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.366M	$1.736M	$2.386M
YoY Change	-40.24%	-27.23%	-39.04%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$306.7K	$329.2K	$580.0K
YoY Change	-33.32%	-43.25%	-43.14%
Total Long-Term Liabilities	$306.7K	$329.2K	$580.0K
YoY Change	-33.32%	-43.25%	-43.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.366M	$1.736M	$2.386M
Total Long-Term Liabilities	$306.7K	$329.2K	$580.0K
Total Liabilities	$1.672M	$2.066M	$2.968M
YoY Change	-39.11%	-30.41%	-39.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$199.2M	-$198.2M	-$196.6M
YoY Change	1.16%	0.82%	1.46%
Common Stock	$669.00	$665.00	$378.00
YoY Change	76.52%	75.93%	-61.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.22M	$24.23M	$5.372M
YoY Change
Total Liabilities & Shareholders Equity	$24.89M	$26.29M	$8.340M
YoY Change	211.31%	215.27%	-1.96%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$1.003M	-$687.1K	-$257.1K
YoY Change	203.94%	167.23%	-81.69%
Depreciation, Depletion And Amortization	-$27.21K	$24.08K	$20.00K
YoY Change	-236.05%	20.4%	-300.0%
Cash From Operating Activities	-$512.5K	-$992.5K	-$520.0K
YoY Change	-283.02%	90.87%	-70.11%
INVESTING ACTIVITIES
Capital Expenditures	-$6.670K	-$41.77K	$10.00K
YoY Change		-517.7%	-133.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$6.670K	-$41.77K	$10.00K
YoY Change		-517.7%	-133.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-122.3K	15.88M	0.000
YoY Change	-711.55%
NET CHANGE
Cash From Operating Activities	-512.5K	-992.5K	-520.0K
Cash From Investing Activities	-6.670K	-41.77K	10.00K
Cash From Financing Activities	-122.3K	15.88M	0.000
Net Change In Cash	-641.4K	14.85M	-510.0K
YoY Change	-313.81%	-3011.64%	-71.19%
FREE CASH FLOW
Cash From Operating Activities	-$512.5K	-$992.5K	-$520.0K
Capital Expenditures	-$6.670K	-$41.77K	$10.00K
Free Cash Flow	-$505.8K	-$950.7K	-$530.0K
YoY Change	-280.64%	79.38%	-69.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33351
	dei	Entity Registrant Name EntityRegistrantName	NEUROMETRIX, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3308180
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
	dei	City Area Code CityAreaCode	781
	dei	Local Phone Number LocalPhoneNumber	890-9989
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	639766	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	334297	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	996951	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1051282	USD
	dei	Trading Symbol TradingSymbol	NURO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6645397	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23213537	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5226213	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	710136	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	478074	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	25560390	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	7089866	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204939	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183494	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	499047	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	692692	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	29293	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	28523	USD
CY2021Q3	us-gaap	Assets Assets	26293669	USD
CY2020Q4	us-gaap	Assets Assets	7994575	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	316969	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	142316	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1028373	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	998442	USD
CY2021Q3	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	46000	USD
CY2020Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	545000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	345147	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	599632	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1736489	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2285390	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	329169	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	461410	USD
CY2021Q3	us-gaap	Liabilities Liabilities	2065658	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2746800	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6645397	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6645397	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3793739	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3793739	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	665	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	379	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	222387601	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	202129195	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-198160256	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196881800	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	24228011	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5247775	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26293669	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7994575	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2064359	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2036228	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6433330	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5568243	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	652671	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1846569	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1599358	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	619833	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	537614	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1754343	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1652890	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	1444526	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	1498614	USD
	us-gaap	Gross Profit GrossProfit	4678987	USD
	us-gaap	Gross Profit GrossProfit	3915353	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	724556	USD
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	442230	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	340927	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1105548	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1144389	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	965711	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	762903	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3254210	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2693146	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2132497	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	1756501	USD
	us-gaap	Operating Expenses OperatingExpenses	5959116	USD
	us-gaap	Operating Expenses OperatingExpenses	5684104	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-687971	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-257887	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1280129	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1768751	USD
CY2021Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	882	USD
CY2020Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	774	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1673	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2323	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-687089	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-257113	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1278456	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1766428	USD
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2530234	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	144047	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	453457	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	43751	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-657371	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	2514118	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	5371772	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5247775	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4197	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	68863	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	128862	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3689974	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7606	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-851944	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	5488616	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	140269	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-257113	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	5261052	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	319863	USD
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3766848	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	18950	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	413178	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-531584	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	8835129	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	196361	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15805110	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	78500	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-687089	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	24228011	USD
	us-gaap	Profit Loss ProfitLoss	-1278456	USD
	us-gaap	Profit Loss ProfitLoss	-1766428	USD
	us-gaap	Depreciation Depreciation	103594	USD
	us-gaap	Depreciation Depreciation	67772	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	585087	USD
	nuro	Compensation Obligation Settlement CompensationObligationSettlement	0	USD
	nuro	Compensation Obligation Settlement CompensationObligationSettlement	43751	USD
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	126748	USD
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	280000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	305469	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	334179	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-54331	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-113421	USD
	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	0	USD
	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	-189008	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	612661	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23621	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	174653	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-533302	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	89931	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-694668	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-499000	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-103000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1561242	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2348068	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	125039	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125039	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	19673605	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4151037	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	773200	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	773200	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19673605	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4151037	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17987324	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1802969	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5226213	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3126206	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23213537	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4929175	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	43751	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	170151	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</span></div>
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-687089	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-257113	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1278456	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1766428	USD
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5818449	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5818449	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3784657	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3784657	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4597580	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4597580	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2755903	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2755903	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.64
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	533455	shares
CY2020Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	24493	USD
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	162435	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	447770	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	186405	shares
CY2021Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	728225	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	716848	USD
CY2021Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	268726	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	334434	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	996951	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1051282	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	49837	USD
CY2021Q3	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	11000	USD
CY2021Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	209000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	343000	USD
CY2021Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	494361	USD
CY2020Q4	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	31000	USD
CY2021Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	33100	USD
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	49600	USD
CY2021Q3	nuro	Technology Fees TechnologyFees	0	USD
CY2020Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2021Q3	nuro	Accrued Leaseholds Current AccruedLeaseholdsCurrent	60000	USD
CY2020Q4	nuro	Accrued Leaseholds Current AccruedLeaseholdsCurrent	0	USD
CY2021Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	111984	USD
CY2020Q3	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	76000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	108928	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	50512	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1028373	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	998442	USD
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	34560	USD
	us-gaap	Sublease Income SubleaseIncome	34560	USD
CY2021Q3	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	0	USD
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	126748	USD
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	280000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	163790	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	247347	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	165785	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165785	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	117431	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	125000	USD
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	166905	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	345147	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	329169	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	860138	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	243289	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	860138	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.147
CY2021Q3	nuro	Operating Lease Discount OperatingLeaseDiscount	185822	USD
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	18932	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	500713	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4197	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	18950	USD
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	50000	shares
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	78500	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7606	USD

Files In Submission

Name	View Source	Status
0001628280-21-020328-index-headers.html	Edgar Link	pending
0001628280-21-020328-index.html	Edgar Link	pending
0001628280-21-020328.txt	Edgar Link	pending
0001628280-21-020328-xbrl.zip	Edgar Link	pending
a10q9302021ex311.htm	Edgar Link	pending
a10q9302021ex312.htm	Edgar Link	pending
a10q9302021ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuro-20210930.htm	Edgar Link	pending
nuro-20210930.xsd	Edgar Link	pending
nuro-20210930_cal.xml	Edgar Link	unprocessable
nuro-20210930_def.xml	Edgar Link	unprocessable
nuro-20210930_htm.xml	Edgar Link	completed
nuro-20210930_lab.xml	Edgar Link	unprocessable
nuro-20210930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2021 Q4 Form 10-Q Financial Statement

#000162828021020328 Filed on October 21, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2021 Q4 Form 10-Q Financial Statement

#000162828021020328 Filed on October 21, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro